Severe Combined Immunodeficiency (SCID) Diagnosis Market, Global Outlook and Forecast 2023-2029

Report ID: MMG194201 | Category: Medical Devices & Consumables | Pages: 69 | Format: PDF | Published Date: September 04,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

SCID (severe combined immunodeficiency) is a group of rare disorders which occurs by mutations in genes involved in the development and function of infection-fighting immune cells. A detailed medical history and physical examination of the child are usually used to diagnose severe combined immunodeficiency (SCID). To help confirm the diagnosis, additional blood tests, including a total blood cell count, may be ordered.SCID (X-linked severe combined immunodeficiency) is an inherited immune system illness that affects virtually exclusively men. Because they lack the required immune cells to fight off some bacteria, viruses, and fungi, boys with X-linked SCID are prone to recurring and persistent illnesses.
This report aims to provide a comprehensive presentation of the global market for Severe Combined Immunodeficiency (SCID) Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Severe Combined Immunodeficiency (SCID) Diagnosis. This report contains market size and forecasts of Severe Combined Immunodeficiency (SCID) Diagnosis in global, including the following market information:
Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Severe Combined Immunodeficiency (SCID) Diagnosis market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
TREC Test Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Severe Combined Immunodeficiency (SCID) Diagnosis include ARCHIMEDlife, PerkinElmer, Health Research, Inc, Winfertility, Portea Medical, LaCAR MDX Technologies, Labsystems Diagnostics Oy, Devyser Diagnostics and Revcovi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Severe Combined Immunodeficiency (SCID) Diagnosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Severe Combined Immunodeficiency (SCID) Diagnosis Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Segment Percentages, by Type, 2022 (%)
    TREC Test
    Complete Blood Count (CBC)
    Genetic Test
    Biochemical Test
    Others
Global Severe Combined Immunodeficiency (SCID) Diagnosis Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Segment Percentages, by Application, 2022 (%)
    Hospital
    Outpatient Center
    Diagnostic and Research Laboratories
    Others
Global Severe Combined Immunodeficiency (SCID) Diagnosis Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Severe Combined Immunodeficiency (SCID) Diagnosis revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Severe Combined Immunodeficiency (SCID) Diagnosis revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    ARCHIMEDlife
    PerkinElmer
    Health Research, Inc
    Winfertility
    Portea Medical
    LaCAR MDX Technologies
    Labsystems Diagnostics Oy
    Devyser Diagnostics
    Revcovi
    Leadiant Biosciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Severe Combined Immunodeficiency (SCID) Diagnosis, market overview.
Chapter 2: Global Severe Combined Immunodeficiency (SCID) Diagnosis market size in revenue.
Chapter 3: Detailed analysis of Severe Combined Immunodeficiency (SCID) Diagnosis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Severe Combined Immunodeficiency (SCID) Diagnosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Severe Combined Immunodeficiency (SCID) Diagnosis Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Severe Combined Immunodeficiency (SCID) Diagnosis Overall Market Size
    2.1 Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Size: 2022 VS 2029
    2.2 Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Severe Combined Immunodeficiency (SCID) Diagnosis Players in Global Market
    3.2 Top Global Severe Combined Immunodeficiency (SCID) Diagnosis Companies Ranked by Revenue
    3.3 Global Severe Combined Immunodeficiency (SCID) Diagnosis Revenue by Companies
    3.4 Top 3 and Top 5 Severe Combined Immunodeficiency (SCID) Diagnosis Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Severe Combined Immunodeficiency (SCID) Diagnosis Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Severe Combined Immunodeficiency (SCID) Diagnosis Players in Global Market
        3.6.1 List of Global Tier 1 Severe Combined Immunodeficiency (SCID) Diagnosis Companies
        3.6.2 List of Global Tier 2 and Tier 3 Severe Combined Immunodeficiency (SCID) Diagnosis Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Size Markets, 2022 & 2029
        4.1.2 TREC Test
        4.1.3 Complete Blood Count (CBC)
        4.1.4 Genetic Test
        4.1.5 Biochemical Test
        4.1.6 Others
    4.2 By Type - Global Severe Combined Immunodeficiency (SCID) Diagnosis Revenue & Forecasts
        4.2.1 By Type - Global Severe Combined Immunodeficiency (SCID) Diagnosis Revenue, 2018-2023
        4.2.2 By Type - Global Severe Combined Immunodeficiency (SCID) Diagnosis Revenue, 2024-2029
        4.2.3 By Type - Global Severe Combined Immunodeficiency (SCID) Diagnosis Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2022 & 2029
        5.1.2 Hospital
        5.1.3 Outpatient Center
        5.1.4 Diagnostic and Research Laboratories
        5.1.5 Others
    5.2 By Application - Global Severe Combined Immunodeficiency (SCID) Diagnosis Revenue & Forecasts
        5.2.1 By Application - Global Severe Combined Immunodeficiency (SCID) Diagnosis Revenue, 2018-2023
        5.2.2 By Application - Global Severe Combined Immunodeficiency (SCID) Diagnosis Revenue, 2024-2029
        5.2.3 By Application - Global Severe Combined Immunodeficiency (SCID) Diagnosis Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2022 & 2029
    6.2 By Region - Global Severe Combined Immunodeficiency (SCID) Diagnosis Revenue & Forecasts
        6.2.1 By Region - Global Severe Combined Immunodeficiency (SCID) Diagnosis Revenue, 2018-2023
        6.2.2 By Region - Global Severe Combined Immunodeficiency (SCID) Diagnosis Revenue, 2024-2029
        6.2.3 By Region - Global Severe Combined Immunodeficiency (SCID) Diagnosis Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Severe Combined Immunodeficiency (SCID) Diagnosis Revenue, 2018-2029
        6.3.2 US Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
        6.3.3 Canada Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
        6.3.4 Mexico Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Severe Combined Immunodeficiency (SCID) Diagnosis Revenue, 2018-2029
        6.4.2 Germany Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
        6.4.3 France Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
        6.4.4 U.K. Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
        6.4.5 Italy Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
        6.4.6 Russia Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
        6.4.7 Nordic Countries Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
        6.4.8 Benelux Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Severe Combined Immunodeficiency (SCID) Diagnosis Revenue, 2018-2029
        6.5.2 China Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
        6.5.3 Japan Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
        6.5.4 South Korea Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
        6.5.5 Southeast Asia Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
        6.5.6 India Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Severe Combined Immunodeficiency (SCID) Diagnosis Revenue, 2018-2029
        6.6.2 Brazil Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
        6.6.3 Argentina Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Severe Combined Immunodeficiency (SCID) Diagnosis Revenue, 2018-2029
        6.7.2 Turkey Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
        6.7.3 Israel Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
        6.7.4 Saudi Arabia Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
        6.7.5 UAE Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, 2018-2029
7 Severe Combined Immunodeficiency (SCID) Diagnosis Companies Profiles
    7.1 ARCHIMEDlife
        7.1.1 ARCHIMEDlife Company Summary
        7.1.2 ARCHIMEDlife Business Overview
        7.1.3 ARCHIMEDlife Severe Combined Immunodeficiency (SCID) Diagnosis Major Product Offerings
        7.1.4 ARCHIMEDlife Severe Combined Immunodeficiency (SCID) Diagnosis Revenue in Global Market (2018-2023)
        7.1.5 ARCHIMEDlife Key News & Latest Developments
    7.2 PerkinElmer
        7.2.1 PerkinElmer Company Summary
        7.2.2 PerkinElmer Business Overview
        7.2.3 PerkinElmer Severe Combined Immunodeficiency (SCID) Diagnosis Major Product Offerings
        7.2.4 PerkinElmer Severe Combined Immunodeficiency (SCID) Diagnosis Revenue in Global Market (2018-2023)
        7.2.5 PerkinElmer Key News & Latest Developments
    7.3 Health Research, Inc
        7.3.1 Health Research, Inc Company Summary
        7.3.2 Health Research, Inc Business Overview
        7.3.3 Health Research, Inc Severe Combined Immunodeficiency (SCID) Diagnosis Major Product Offerings
        7.3.4 Health Research, Inc Severe Combined Immunodeficiency (SCID) Diagnosis Revenue in Global Market (2018-2023)
        7.3.5 Health Research, Inc Key News & Latest Developments
    7.4 Winfertility
        7.4.1 Winfertility Company Summary
        7.4.2 Winfertility Business Overview
        7.4.3 Winfertility Severe Combined Immunodeficiency (SCID) Diagnosis Major Product Offerings
        7.4.4 Winfertility Severe Combined Immunodeficiency (SCID) Diagnosis Revenue in Global Market (2018-2023)
        7.4.5 Winfertility Key News & Latest Developments
    7.5 Portea Medical
        7.5.1 Portea Medical Company Summary
        7.5.2 Portea Medical Business Overview
        7.5.3 Portea Medical Severe Combined Immunodeficiency (SCID) Diagnosis Major Product Offerings
        7.5.4 Portea Medical Severe Combined Immunodeficiency (SCID) Diagnosis Revenue in Global Market (2018-2023)
        7.5.5 Portea Medical Key News & Latest Developments
    7.6 LaCAR MDX Technologies
        7.6.1 LaCAR MDX Technologies Company Summary
        7.6.2 LaCAR MDX Technologies Business Overview
        7.6.3 LaCAR MDX Technologies Severe Combined Immunodeficiency (SCID) Diagnosis Major Product Offerings
        7.6.4 LaCAR MDX Technologies Severe Combined Immunodeficiency (SCID) Diagnosis Revenue in Global Market (2018-2023)
        7.6.5 LaCAR MDX Technologies Key News & Latest Developments
    7.7 Labsystems Diagnostics Oy
        7.7.1 Labsystems Diagnostics Oy Company Summary
        7.7.2 Labsystems Diagnostics Oy Business Overview
        7.7.3 Labsystems Diagnostics Oy Severe Combined Immunodeficiency (SCID) Diagnosis Major Product Offerings
        7.7.4 Labsystems Diagnostics Oy Severe Combined Immunodeficiency (SCID) Diagnosis Revenue in Global Market (2018-2023)
        7.7.5 Labsystems Diagnostics Oy Key News & Latest Developments
    7.8 Devyser Diagnostics
        7.8.1 Devyser Diagnostics Company Summary
        7.8.2 Devyser Diagnostics Business Overview
        7.8.3 Devyser Diagnostics Severe Combined Immunodeficiency (SCID) Diagnosis Major Product Offerings
        7.8.4 Devyser Diagnostics Severe Combined Immunodeficiency (SCID) Diagnosis Revenue in Global Market (2018-2023)
        7.8.5 Devyser Diagnostics Key News & Latest Developments
    7.9 Revcovi
        7.9.1 Revcovi Company Summary
        7.9.2 Revcovi Business Overview
        7.9.3 Revcovi Severe Combined Immunodeficiency (SCID) Diagnosis Major Product Offerings
        7.9.4 Revcovi Severe Combined Immunodeficiency (SCID) Diagnosis Revenue in Global Market (2018-2023)
        7.9.5 Revcovi Key News & Latest Developments
    7.10 Leadiant Biosciences
        7.10.1 Leadiant Biosciences Company Summary
        7.10.2 Leadiant Biosciences Business Overview
        7.10.3 Leadiant Biosciences Severe Combined Immunodeficiency (SCID) Diagnosis Major Product Offerings
        7.10.4 Leadiant Biosciences Severe Combined Immunodeficiency (SCID) Diagnosis Revenue in Global Market (2018-2023)
        7.10.5 Leadiant Biosciences Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Severe Combined Immunodeficiency (SCID) Diagnosis Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?